abrdn Life Sciences Investors (HQL) Stock Price

HQLStock
$21.67+55.82%52W
Market Cap$658.94M
P/E7.35x
PEG Ratio
Div yield
Beta0.71

HQL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)11.90%
Price vs S&P 500 (4W)8.20%
VGM Score64.72
P/E Ratio (Annual)7.35x

Industry Peers — Unclassified(45)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
HQLabrdn Life Sciences Investors
DBA$21.67
NVGNuveen AMT-Free Municipal Credit Income FundCDD$12.27
TYTRI-Continental CorporationABB$35.61
CETCentral Securities Corp.DBB$55.29
GAMGeneral American Investors Company, Inc.A$67.95
HQHabrdn Healthcare InvestorsFBA$23.61
MQYBlackrock Muni Yield Quality Fund, IncDCD$11.15
MYIBLACKROCK MUNIYIELD QUALITY FUND III, INC.DCC$10.78
MUABlackrock Muni Assets Fund, Inc.CCF$9.99
PDTJohn Hancock Premium Dividend FundF$12.62
FAXabrdn Asia-Pacific Income Fund, IncACD$14.60

About abrdn Life Sciences Investors

abrdn Life Sciences Investors is a non-diversified, closed-end fund focused on long-term capital appreciation in the life sciences sector. It invests in both public and private companies with above-average growth potential. The fund's strategy targets companies believed capable of delivering superior returns.